Pre-pectoral Tissue Expander and Acellular Dermal Matrix for a Two-stage Muscle Sparing Breast Reconstruction
1 other identifier
observational
44
1 country
1
Brief Summary
The aim of the research is to evaluate clinical outcomes of a two stage muscle sparing prepectoral breast reconstruction using tissue expander (TE) entirely covered by an ADM. The authors aim to report surgical indications, technical tips, clinical and histological outcomes with the final objective of delineate a decision-making algorithm for immediate prosthetic breast reconstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 18, 2024
April 1, 2024
4.8 years
April 4, 2024
April 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Patient satisfaction
Patients satisfaction will be evaluated through BREAST-Q questionnaire. the results from the questionnaire will be converted into a 0-100 scale with higher values meaning a better outcome
24 months of follow-up
Secondary Outcomes (1)
Pain Evaluation
24 months of follow-up
Other Outcomes (1)
Complication rate
24 months of follow-up
Interventions
breast reconstruction in two-stages using tissue expander entirely wrapped by acellular dermal matrix
Eligibility Criteria
consecutive patients who undergo two stage breast recontrustion with tissue expander and ADM
You may qualify if:
- unilateral or bilateral mastectomy followed by two stage breast reconstruction with subcutaneous tissue expander and Acellular Dermal Matrix (ADM)
- risk-reducing mastectomies followed by two stage breast reconstruction with subcutaneous tissue expander and ADM
You may not qualify if:
- partial or total submuscular tissue expander placement,
- tissue expander placement in conjunction with latissimus dorsi muscle flap or without ADM, -delayed reconstructions
- previous breast surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Policlinico
Bari, BA, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Giuseppe Giudice
University of Bari
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Full time researcher, Unit of Plastic and Reconstructive Surgery, Policlinico of Bari
Study Record Dates
First Submitted
April 4, 2024
First Posted
April 18, 2024
Study Start
June 1, 2019
Primary Completion
April 1, 2024
Study Completion
December 31, 2024
Last Updated
April 18, 2024
Record last verified: 2024-04